Trials / Recruiting
RecruitingNCT06726889
Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Optimizing an Intervention to Increase Oral Medication Adherence for Metastatic Breast Cancer Patients
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 104 (estimated)
- Sponsor
- European Institute of Oncology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
Detailed description
Today different types of Oral Anticancer Agents (OAA) are commonly prescribed to Breast Cancer (BC) patients. Patients are reported to prefer the oral modality of administration over the intravenous one for its convenience, flexibility, and easier assumption; nonetheless, the phenomenon of medication non-adherence is well-documented. Although several interventions have been designed and tested in order to foster medication adherence among BC patients, the great majority of them were focused on adherence to endocrine therapy for early-stage BC patients, with only few exceptions involving metastatic BC patients or considering adherence to other types of OAA. The aim of this work is to optimize an adherence increasing intervention designed for metastatic BC patients. This will be achieved by applying a full factorial design in order to evaluate the optimal combination of three different intervention components (informative documentation, personalized reminders and feedback).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Standard care | Patient will not receive any additional interventions |
| BEHAVIORAL | Decision Support System (DSS) | DSS will be used to deliver educational material through a web-page (in Italian language) accessible through a link |
| BEHAVIORAL | Reminders | Personalized reminders will be delivered to patients through a common messaging application (WhatsApp) |
| BEHAVIORAL | Feedback | Feedback message will be delivered by physician to patients, through WhatsApp, after medication diary revision |
Timeline
- Start date
- 2024-01-25
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
- First posted
- 2024-12-10
- Last updated
- 2024-12-20
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06726889. Inclusion in this directory is not an endorsement.